furosemide / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   79 Trials   79 Trials   6783 News 


«12...3233343536373839404142...8687»
  • ||||||||||  captopril / Generic mfg., furosemide / Generic mfg.
    Clinical, Journal:  Ruptura septal de localización atípica posterior a infarto del miocardio. Caso clínico (Pubmed Central) -  Nov 5, 2021   
    El paciente recibió tratamiento médico con captopril, furosemida y espironolactona, sin mejoría de los síntomas, motivo por el cual se lo refirió a la institución de los autores. Al llegar al servicio de urgencias, el sujeto se encontraba estable.
  • ||||||||||  dobutamine / Generic mfg.
    DOBUTAMINE-INDUCED EOSINOPHILIA (Hall B (1st Floor); Monitor 01) -  Nov 2, 2021 - Abstract #ACAAI2021ACAAI_694;    
    This case exhibits an unusual complication of a widely used inotrope. In this case, recognizing the temporal relation between the rise of the eosinophil count and drug administration helped determine the offending agent.
  • ||||||||||  furosemide / Generic mfg.
    Clinical, Journal:  The Use of Diuretic in Mechanically Ventilated Children with Viral Bronchiolitis: a Cohort Study. (Pubmed Central) -  Nov 1, 2021   
    Of the 224 mechanically ventilated children with confirmed bronchiolitis, 179 (79%) received furosemide on Day 2 of invasive ventilation...There is a potential benefit of improved oxygenation in these children, though further research is needed to quantify this benefit and any potential harm. Due to potential harm with fluid overload, restrictive fluid strategies may have a potential benefit.
  • ||||||||||  furosemide / Generic mfg.
    Journal:  Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure. (Pubmed Central) -  Oct 31, 2021   
    This issue may have possible benefits on clinical practice concerning its therapeutic effects over and beyond the simple amelioration of clinical congestion signs and symptoms. Nevertheless, our findings of higher delta values after treatment with i.v. furosemide plus HSS indicate a possible higher efficacy by means of modulation of the stretching and fibrosis mechanisms.
  • ||||||||||  Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca
    Clinical, Journal:  Prospective association of serum adipocyte fatty acid-binding protein with heart failure hospitalization in diabetes. (Pubmed Central) -  Oct 31, 2021   
    Nevertheless, our findings of higher delta values after treatment with i.v. furosemide plus HSS indicate a possible higher efficacy by means of modulation of the stretching and fibrosis mechanisms. Circulating AFABP level is independently associated with incident HF hospitalization in type 2 diabetes and is potentially helpful in risk stratification for the prevention of HF hospitalization.
  • ||||||||||  furosemide / Generic mfg.
    Journal:  Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge. (Pubmed Central) -  Oct 30, 2021   
    There was a small increase in exposure of furosemide and rosuvastatin; however, these increases are not expected to be of clinical relevance. Spot UNa assessed at early phase of hospitalization and at discharge have different prognostic significance, which confirms that it should be always interpreted along with clinical context.
  • ||||||||||  furosemide / Generic mfg.
    Clinical, Journal:  Case Studies in Physiology: Untangling the cause of hypoxemia in an obese patient with acute leukemia. (Pubmed Central) -  Oct 30, 2021   
    Using basic physiological principles, we describe how hypoventilation, anemia, and the use of a β blocker and furosemide, collaborated to create a "perfect storm" in this patient that impaired oxygen delivery and limited utilization...Using basic physiological principles, we describe how hypoventilation, anemia, and the use of a beta-blocker and furosemide, collaborated to create a "perfect storm" in this patient that impaired oxygen delivery and limited utilization. This case illustrates the application of innovative physiology methodology in medicine and provides strong rationale for continuing to integrate physiology education in medical education.
  • ||||||||||  ketamine / Generic mfg., furosemide / Generic mfg., dexmedetomidine / Generic mfg.
    Journal:  Effect of furosemide on dexmedetomidine anaesthesia in cats. (Pubmed Central) -  Oct 30, 2021   
    It was concluded that concurrent administration of furosemide with dexmedetomidine- anaesthesia in cats prolonged the duration of analgesia and recumbency but had no effect on onset of anaesthesia. A cat on this anaesthetic combination concurrently placed on furosemide medication will therefore need to be carefully monitored until full recovery.
  • ||||||||||  furosemide / Generic mfg.
    Journal:  A Bayesian multiple imputation approach to bivariate functional data with missing components. (Pubmed Central) -  Oct 29, 2021   
    The motivating renal study aims to investigate the distribution and pharmacokinetic properties of baseline and post-furosemide renogram curves that provide further insights into the underlying mechanism of renal obstruction, with post-furosemide renogram curves missing for some subjects. We apply the proposed methods to impute missing post-furosemide renogram curves and obtain more refined insights.
  • ||||||||||  sildenafil / Generic mfg.
    [VIRTUAL] SECONDARY POLYCYTHEMIA TO HYPOXEMIA IN A PATIENT WITH DOWN SYNDROME WHO PRESENTS CONGENITAL HEART DISEASE: A CASE REPORT () -  Oct 27, 2021 - Abstract #HEMO2021HEMO_1519;    
    Its carriers have several common physical characteristics and increased incidence of several congenital malformations, with heart disease, defined as changes in the structure or function of the heart, such as more prevalent. Thus, an early diagnosis, especially in the prenatal period, can direct medical action towards a more favorable prognosis.Objectives To report a case of polycythemia secondary to recurrent hypoxemia in a patient with Down's Syndrome who presents with congenital heart disease followed up in a hematology clinic in the interior of the Northeast.Design and Methods Data collected from the medical record, describing the examinations performed and the patient's general health status during the period in which she was followed.Results Male patient, 22 years old, with Down syndrome, congenital heart disease, Hypothyroidism and severe chronic pulmonary hypertension is monitored in the hematology clinic for polycythemia secondary to hypoxemia. In his last appointment on 11/18/2019, his exams showed: Hb = 21.3g/dl; Ht = 61%; VCM = 98; HCM = 33.7; CHCM = 34.5; RDW = 11.9%; leukocytes = 5,120/mm³; lymphocytes=41.6%; monocytes = 8.2%; segmented = 47.3%; eosinophils = 1.3%; basophil = 1.6%; platelets = 112,000/mm; ferritin = 35. Protein electrophoresis: Albumin = 4.55; a1-Globulin = 0.32; α2-globulin = 0.79; B-globulin = 0.5; Beta 2 = 0.52; Globulin range = 1.5. On physical examination: HR = 96 bpm; O2 saturation = 96%; BP 100 × 80 mmHg (right upper limb) and 90 × 70 mmHg (left upper limb), in the skin, presence of hyperemia on the back with punctiform lesions, abdomen and upper limbs. Palpable thyroid (Left lobe > right lobe) of fibroelastic consistency. The approach adopted since the beginning of follow-up is the regular use of bloodletting. Makes regular use of Sildenafil 20mg 8/8 hours, Puran T4 50 mg with coffee, Lasix 40 mg 1 × a day, Combiron 1 tablet a day. Polycythemia, in this case, appears as a mechanism of adaptation to hypoxia caused by pulmonary hypertension associated with a defect in the total atrioventricular septum and attriventricular valves. Laboratory tests rule out evidence of Polycythemia Vera.Conclusion s The case reported brings to the Discussion a complex situation and shows that regular monitoring and well-executed therapy obtain satisfactory Results in improving the patient's quality of life. Since, during years of follow-up, the patient has been stabilized.
  • ||||||||||  furosemide / Generic mfg.
    Clinical, Review, Journal:  Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial. (Pubmed Central) -  Oct 27, 2021   
    P3
    Given this gap in knowledge and the fundamental role of loop diuretic agents in HF care, the TRANSFORM-HF trial was designed as a prospective, randomized, event-driven, pragmatic, comparative-effectiveness study to definitively compare the effect of a treatment strategy of torsemide versus furosemide on long-term mortality, hospitalization, and patient-reported outcomes among patients with HF. (TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure [TRANSFORM-HF]; NCT03296813).
  • ||||||||||  furosemide / Generic mfg.
    Retrospective data, Journal:  Explainable machine learning model to predict refeeding hypophosphatemia. (Pubmed Central) -  Oct 22, 2021   
    The machine learning model for predicting RFS has a substantially higher effectiveness than conventional regression methods. Creating an accurate risk assessment tool based on machine learning for early identification of patients at risk for RFS can enable careful nutrition management planning and monitoring in the intensive care unit, towards reducing the incidence of RFS-related morbidity and mortality.
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    [VIRTUAL] ANCA Vasculitis: Detecting It Early () -  Oct 17, 2021 - Abstract #KIDNEYWEEK2021KIDNEY_WEEK_3794;    
    The patient’s renal function deteriorated even after losartan and furosemide were discontinued and nephrology was consulted when Cr was 2.23...Despite induction therapy with Solumedrol followed by weekly rituximab x 4 doses, renal function continued to decline...Treatment requires pulse methylprednisolone with 500 to 1000mg/day for three days followed by oral prednisone along with cyclophosphamide or rituximab. In rapidly decline in Cr continues, plasmapheresis is warranted.